Large gap with delayed quotes
|
Last quote
04/25/2026
-
02:00:00
|
Bid
04/27/2026 -
14:45:00
|
Bid Volume |
Ask
04/27/2026 -
14:45:00
|
Ask Volume |
|---|---|---|---|---|
|
3.44
-0.04
(
-1.15% )
|
3.40
|
1,100 |
3.59
|
100 |
Analysis date: 24.04.2026
Global Evaluation
Negativ
Negativ
The stock is classified in the negative zone since 24.04.2026.
Interest
Very weak
Very weak
One star since 24.04.2026.
Earnings Rev Trend
0.10
0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 27.02.2026 at a price of 3.86.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 24.04.2026.
4wk Rel Perf
-14.26%
-14.26%
The four-week dividend-adjusted underperformance versus SP500 is 14.26%.
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 8.09%.
Mkt Cap in $bn
1.54
1.54
With a market capitalization <$2bn, IOVANCE BIOTHERAPEUTICS is considered a small-cap stock.
G/PE Ratio
0.87
0.87
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
-39.56
-39.56
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
34.25%
34.25%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
8
8
Over the last seven weeks, an average of 8 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
131
131
For 1% of index variation, the stock varies on average by 1.31%.
Correlation
0.14
0.14
Stock movements are totally independent of index variations.
Value at Risk
3.12
3.12
The value at risk is estimated at USD 3.12. The risk is therefore 90.81%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
08.09.2020
08.09.2020